| scholarly article | Q13442814 |
| P2093 | author name string | Lee TH | |
| Busch MP | |||
| Chrebtow V | |||
| Montalvo L | |||
| P2860 | cites work | Isolation and characterization of DNA from the plasma of cancer patients | Q34186554 |
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Microsatellite alterations in serum DNA of head and neck cancer patients | Q34394745 | ||
| Neoplastic characteristics of the DNA found in the plasma of cancer patients | Q34543792 | ||
| Quantitation of hepatitis B virus DNA in serum by ammonium sulfate precipitation and molecular hybridization | Q40743550 | ||
| Free DNA in serum and plasma from normal adults | Q40982175 | ||
| Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia | Q42025177 | ||
| Quantitation of residual white cells in filtered blood components by polymerase chain reaction amplification of HLA DQ-A DNA. | Q46577502 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 276-282 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Transfusion | Q15758500 |
| P1476 | title | Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma | |
| P478 | volume | 41 |
| Q48178985 | A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications |
| Q34237017 | A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study |
| Q40126026 | A modified extraction method of circulating free DNA for epidermal growth factor receptor mutation analysis |
| Q91707609 | A quantitative analysis of the potential biomarkers of non-small cell lung cancer by circulating cell-free DNA |
| Q35643156 | Aberrant methylation of the PTPRO gene in peripheral blood as a potential biomarker in esophageal squamous cell carcinoma patients |
| Q50097469 | Analysis of tumour-derived DNA in serum in advanced non-microcytic lung cancer: might it be a prognostic factor? |
| Q33797039 | Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients |
| Q34339354 | Bartonella henselae infection in a family experiencing neurological and neurocognitive abnormalities after woodlouse hunter spider bites. |
| Q38686561 | Cell-free DNA - Minimally invasive marker of hematological malignancies |
| Q47206216 | Cell-free DNA as a biomarker in stroke: Current status, problems and perspectives |
| Q28074556 | Cell-free DNA as a diagnostic marker for cancer: current insights |
| Q58113203 | Cell-free DNA in cancer: current insights |
| Q54469768 | Cell-free DNA in the plasma of patients with systemic sclerosis. |
| Q58114470 | Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review |
| Q35023094 | Circulating DNA in plasma and serum: biology, preanalytical issues and diagnostic applications |
| Q33868324 | Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients |
| Q34121782 | Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma |
| Q34999413 | Circulating DNA: a new diagnostic gold mine? |
| Q92594244 | Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019 |
| Q38664513 | Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis |
| Q48486711 | Circulating free DNA in plasma or serum as biomarkers of carcinogenesis in colon cancer |
| Q61810143 | Circulating free tumor DNA in non-small cell lung cancer (NSCLC): clinical application and future perspectives |
| Q51498128 | Circulating molecular markers in pancreatic cancer: ready for clinical use? |
| Q38002907 | Circulating nucleic acids and protease activities in blood of tumor patients |
| Q37690454 | Circulating nucleic acids in cancer and pregnancy |
| Q91742610 | Circulating tumor DNA in colorectal cancer: opportunities and challenges |
| Q35125657 | Circulating tumour markers can define patients with normal colons, benign polyps, and cancers |
| Q57161777 | Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA |
| Q35129464 | Coinfection of human herpesviruses 6A (HHV-6A) and HHV-6B as demonstrated by novel digital droplet PCR assay |
| Q46578913 | Colorectal Cancer Blood-Based Biomarkers. |
| Q53482447 | Colorectal cancer: using blood samples and tumor tissue to detect K-ras mutations. |
| Q89692421 | Comparison of paired cerebrospinal fluid and serum cell-free mitochondrial and nuclear DNA with copy number and fragment length |
| Q47152528 | Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients |
| Q34921290 | Complete genes may pass from food to human blood. |
| Q42361143 | DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer |
| Q37148677 | DNA methylation as clinically useful biomarkers-light at the end of the tunnel |
| Q54639515 | Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients. |
| Q55461647 | Detection of serum Alu element hypomethylation for the diagnosis and prognosis of glioma. |
| Q49296229 | Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model |
| Q35543094 | Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology |
| Q54625845 | Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays. |
| Q90664767 | Enrichment and Analysis of ctDNA |
| Q38115621 | Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer |
| Q36068098 | Evaluation of an Improved Non-invasive Fetal Sex Determination in Haemophilia A Patients |
| Q35879537 | Genotyping Patients With Recent Blood Transfusions |
| Q38249332 | Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance |
| Q64230173 | Genotyping of Single Nucleotide Polymorphisms Using Allele-Specific qPCR Producing Amplicons of Small Sizes Directly from Crude Serum Isolated from Capillary Blood by a Hand-Powered Paper Centrifuge |
| Q34502843 | Global screening for human viral pathogens |
| Q60919801 | Impact of Blood Collection Tubes and Sample Handling Time on Serum and Plasma Metabolome and Lipidome |
| Q34596601 | K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking |
| Q49740946 | Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer |
| Q92154338 | Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges |
| Q28285049 | Lung cancer epigenetics: emerging biomarkers |
| Q36270673 | Luteal phase serum cell-free DNA as a marker of failed pregnancy after assisted reproductive technology |
| Q37708509 | Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer |
| Q28072859 | Methylation analyses in liquid biopsy |
| Q28085699 | Methylation of cell-free circulating DNA in the diagnosis of cancer |
| Q33832718 | Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma |
| Q48141047 | Molecular typing for blood group antigens within 40 min by direct polymerase chain reaction from plasma or serum |
| Q33921152 | Naturally acquired microchimerism |
| Q91817474 | Noncoding RNAs and Liquid Biopsy in Lung Cancer: A Literature Review |
| Q38216129 | Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies. |
| Q92015499 | Opportunities and challenges of circulating biomarkers in neuroblastoma |
| Q31157538 | Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine. |
| Q51134087 | Plasma DNA methylation of p16 and shp1 in patients with B cell non-Hodgkin lymphoma. |
| Q33790229 | Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker |
| Q42373320 | Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics. |
| Q37960201 | Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer |
| Q51733621 | Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients. |
| Q84584139 | Quantitation of plasma circulating DNA using quantitative PCR for the detection of hepatocellular carcinoma |
| Q35995428 | Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients |
| Q38359104 | Quantitative analysis of male fetal DNA in maternal serum of gravid rhesus monkeys (Macaca mulatta). |
| Q36464145 | Real-time PCR quantification of plasma DNA in non-small cell lung cancer patients and healthy controls |
| Q41818166 | Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. |
| Q42687570 | Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring |
| Q59233182 | Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer |
| Q34132740 | Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades |
| Q90362007 | Serum Has Higher Proportion of Janus Kinase 2 V617F Mutation Compared to Paired EDTA-Whole Blood Sample: A Model for Somatic Mutation Quantification Using qPCR and the 2-∆∆Cq Method |
| Q48510469 | Serum and Plasma Copy Number Detection Using Real-time PCR. |
| Q46530603 | Serum methylation levels of TAC1. SEPT9 and EYA4 as diagnostic markers for early colorectal cancers: a pilot study |
| Q61801746 | Technical and Regulatory Considerations for Taking Liquid Biopsy to the Clinic: Validation of the JAX PlasmaMonitor Assay |
| Q35879299 | The biology and diagnostic applications of fetal DNA and RNA in maternal plasma |
| Q39068458 | The clinical role of circulating free tumor DNA in gastrointestinal malignancy |
| Q82665040 | The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma |
| Q35752134 | The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer |
| Q36813298 | The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes. |
| Q54023394 | Viral metagenomics |
| Q34826830 | Y-chromosome DNA is present in the blood of female dogs suggesting the presence of fetal microchimerism |
Search more.